ISC 2018: WEAVE Post-Market Data Boost Stryker's Wingspan Brain Stent
Executive Summary
Stryker's Wingspan intracranial stent, the subject of controversy several years ago when a post-market trial showed an unexpectedly high risk of adverse events with the device, can be deployed effectively with minimal risk in the specific patient population indicated on its label, results of the WEAVE study show.